Archit Organosys reported a robust revenue growth of 94% year-on-year to Rs 63.99 crore for the quarter ended September 30, 2026. However, net profit remained flat at Rs 1.54 crore as operational expenses increased significantly. The company, operating in the chemicals and organics segment, also reported an improvement in half-yearly cash flow from operations to Rs 8.56 crore.
Archit Organosys Reports Significant Revenue Growth in Q2 FY27
Revenue from operations reached Rs 63.99 crore for the quarter; net profit stood at Rs 1.54 crore.
Reader Takeaway: Strong top-line expansion signals market scale, but rising operating expenses are currently capping bottom-line profitability growth.
What just happened
Archit Organosys Limited released its financial results for the quarter and half-year ended September 30, 2026. The company saw a massive jump in its revenue from operations, which climbed to Rs 63.99 crore from Rs 32.86 crore in the same quarter last year. Despite this nearly doubling of top-line performance, the company's net profit remained unchanged at Rs 1.54 crore, indicating that input or operating costs have risen in tandem with business activity.
Why this matters
The doubling of revenue highlights strong demand in the company’s core 'Chemicals and Organics' segment. However, the flat profit growth suggests that the company is currently struggling to translate this revenue growth into higher earnings for shareholders, likely due to inflationary pressure on raw materials or increased operational overheads.
Operating Performance
Total expenses for the September quarter surged to Rs 62.74 crore, up from Rs 32.35 crore in the prior year. While the revenue growth is impressive, the company’s cost management will be a key area for investors to monitor in coming quarters to see if margins begin to expand.
Context Metrics
On a half-year basis, revenue rose to Rs 101.08 crore compared to Rs 66.06 crore in the same period last year. Net profit for the first six months of the fiscal year reached Rs 2.99 crore, compared to Rs 3.58 crore in the corresponding half-year of 2025. Trade receivables have increased to Rs 39.44 crore as of September 30, 2026, up from Rs 24.55 crore at the end of March 2026, suggesting longer working capital cycles.
What to track next
Investors should watch for commentary on cost-control initiatives and the impact of the rising trade receivables on the company's liquidity position in the upcoming quarters.